Clinical Trial Update: SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial) [Phase 2]

View source ↗

Summary

The Phase 2 trial of SIKAMIC for sickle cell disease, evaluating kidney function and albuminuria, has completed. Results were posted on 2025-05-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• SIKAMIC

Snippet

Sponsor: Theravia | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-05-14